Publicacions destacades

Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)

Oro-Ayude, M; Gonzalez-Sixto, B; Sanmartin-Jimenez, O; Garces, JR; Rodriguez-Prieto, MA;

(...)

Suarez-Fernandez, R; Sainz-Gaspar, L; Descalzo, MA; Garcia-Doval, I; Florez, A.

Referència:
Journal Of The European Academy Of Dermatology And Venereology 2022.
Detection of cell-free circulating BRAFV 600E by droplet digital PCR in melanoma and non-melanoma patients under dermatological surveillance

Calbet-Llopart, N; Potrony, M; Tell-Marti, G; Carrera, C; Barreiro, A;

Aguilera, P; Podlipnik, S; Puig, S; Malvehy, J; Puig-Butille, J A.

Referència:
British Journal Of Dermatology 2020.
Inherited MC1R variants in melanoma patients are associated with better survival in females

Lira, F E; Podlipnik, S; Potrony, M; Tell-Marti, G; Calbet-Llopart, N;

Barreiro, A; Carrera, C; Malvehy, J; Puig, S.

Referència:
British Journal Of Dermatology 2020.
Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations

da Silva, VM; Martinez-Barrios, E; Tell-Marti, G; Dabad, M; Carrera, C;

(...)

Esteve-Codina, A; Vicente, A; Puig, S; Puig-Butille, JA; Malvehy, J.

Referència:
Journal Of Investigative Dermatology 2019.
Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with AJCC stage IIB, IIC and III malignant melanoma.

Podlipnik S; Moreno-Ramírez D; Carrera C; Barreiro A; Manubens E;

Ferrandiz-Pulido L; Sánchez M; Vidal-Sicart S; Malvehy J; Puig S .

Referència:
British Journal Of Dermatology 2019.
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families

Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD;

(...)

Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S .

Referència:
British Journal Of Dermatology 2019.
Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients

Podlipnik S; Carrera C; Boada A; Richarz NA; López-Estebaranz JL;

(...)

Carrillo-Gijón R; Redondo P; Moreno E; Malvehy J; Puig S .

Referència:
Journal Of The European Academy Of Dermatology And Venereology 2019.
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson V;

(...)

Ibrahim N; Marreaud S; van Akkooi ACJ; Suciu S; Robert C .

Referència:
New England Journal Of Medicine 2018.
Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.

Vallone MG; Tell-Marti G; Potrony M; Rebollo-Morell A; Badenas C;

Puig-Butille JA; Gimenez-Xavier P; Carrera C; Malvehy J; Puig S .

Referència:
Pigment Cell & Melanoma Research 2018.
Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study

Podlipnik S; Carrera C; Sánchez M; Arguis P; Olondo ML;

(...)

Vidal-Sicart S; Vilalta A; Conill C; Malvehy J; Puig S .

Referència:
Journal Of The American Academy Of Dermatology 2016.